Eli Operating Income from 2010 to 2025
| LLY Stock | USD 1,077 0.00 0.00% |
Operating Income | First Reported 1985-09-30 | Previous Quarter 7.1 B | Current Value 7.7 B | Quarterly Volatility 1.2 B |
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 955.6 M, Interest Expense of 819.6 M or Total Revenue of 47.3 B, as well as many indicators such as Price To Sales Ratio of 16.21, Dividend Yield of 0.0064 or PTB Ratio of 51.44. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
Eli | Operating Income | Build AI portfolio with Eli Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.